NCT06384417Completed
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
Adapting an Advance Care Planning Intervention for Use With Patients With Cancer and Their Care Partners: Phase Two
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
The goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with various solid cancer types (including: breast, gastro-intestinal, lung, melanoma, head and neck, and/or genito-urinary cancers) treated at Penn State Health clinics and their loved ones perform advance care planning (ACP). The main questions it aims to answer are: What modifications and/or adaptations are necessary to Hello for use in cancer populations? What impact does participation in Hello event have on health care usage (e.g., number of hospitalizations, ICU admissions, emergency department visits, etc.)? How feasible is it to randomize participants to play either Hello for Cancer or Table Topics? Participants will: * Complete pre-game questionnaires * Play either Hello or Table Topics game * Complete post-game questionnaires * Participate in a focus group * Complete a telephone follow up interview 1-4 months after their event This study is a continuation of NCT06028152.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 22 Apr 2024
- Start date
- 27 Jun 2024
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Milton S. Hershey Medical Center
- Diseases
- Head and neck cancer, Melanoma, Lung cancer, Pancreatic cancer, Colorectal cancer, Liver and biliary tract cancer, Gastric and esophageal cancer
- NCT number
- NCT06384417
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 27 Jun 2024 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Has not received treatment for their cancer at a Penn State Health facility in the past year
Other illness
- Has completed an advance directive since cancer diagnosis as verified by presence in the patient's medical chart
Other
- Unable to consent to participate in study
- \* Unable to consent to participate in study
Who the study is looking for
- Adults (\> 18 years old)
- Able to speak and read English and/or Spanish
- Be an individual diagnosed with a solid tumor cancer (e.g., breast, colon, lung, melanoma, head and neck, or genitourinary/prostate cancer) as verified by primary oncologist or is the chosen caregiver for a participant with those cancers
- Receives care at Penn State Health or is the chosen caregiver for a participant treated at Penn State Health
- Adults (\> 18 years old)
- Able to speak and read English and/or Spanish
- Be the chosen caregiver for a participant with cancer
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Penn State Cancer Institute Coordinator of this site? Confirm its status | Hershey | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.